MiNA Therapeutics

📍 London, United Kingdom🗓 Founded 2008👥 39 employees💰 Last funded Jan 2016
Biotechnology🌐 minatx.com
Website LinkedIn
Harnessing an innate mechanism of gene activation, MiNA Therapeutics'​ platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in MiNA Therapeutics?
MiNA Therapeutics has 2 investors on record on gritt.io and 2 late-stage investors.
When did MiNA Therapeutics last raise funding?
The most recent investment in MiNA Therapeutics recorded on gritt.io was in January 2016.
When was MiNA Therapeutics founded?
MiNA Therapeutics was founded in 2008.
What industry is MiNA Therapeutics in?
MiNA Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is MiNA Therapeutics based?
MiNA Therapeutics is headquartered in London, United Kingdom.